These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15623079)

  • 21. Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving?
    Kassimis G; De Maria GL; Patel N; Banning AP
    Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):997-1003. PubMed ID: 24939631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery.
    Stephan WJ; O'Keefe JH; Piehler JM; McCallister BD; Dahiya RS; Shimshak TM; Ligon RW; Hartzler GO
    J Am Coll Cardiol; 1996 Nov; 28(5):1140-6. PubMed ID: 8890807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis of major clinical outcomes using drug-eluting stents versus bare metal stents in diabetic versus nondiabetic patients.
    Minha S; Bental T; Assali A; Vaknin-Assa H; Lev EI; Rechavia E; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Nov; 78(5):710-7. PubMed ID: 21805561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Percutaneous coronary intervention in patients with diabetes mellitus].
    Søndergaard HM; Bøtker HE; Bøttcher M; Nielsen TT
    Ugeskr Laeger; 2003 Jan; 165(2):111-5. PubMed ID: 12553090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy insight: diabetes and drug-eluting stents.
    Legrand V
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):143-50. PubMed ID: 17330126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coronary revascularization of coronary artery disease in patients with diabetes].
    Tsuboi S; Miyauchi K
    Nihon Rinsho; 2011 Feb; 69(2):329-34. PubMed ID: 21387685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coronary angioplasty in diabetic patients].
    Steffenino G; La Scala E; Riva L; Menardi E
    Ital Heart J Suppl; 2002 Jan; 3(1):9-15. PubMed ID: 11899579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coronary angioplasty in diabetic patients. Current and future perspectives].
    Alonso JJ; Durán JM; Gimeno F; Ramos B; Serrador A; Fernández-Avilés F
    Rev Esp Cardiol; 2002 Nov; 55(11):1185-200. PubMed ID: 12423576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting.
    Kiernan TJ; Yan BP; Cruz-Gonzalez I; Cubeddu RJ; Caldera A; Kiernan GD; Gupta V
    Cardiovasc Hematol Agents Med Chem; 2008 Apr; 6(2):116-24. PubMed ID: 18473776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac complications in non-insulin-dependent diabetes mellitus.
    Julien J
    J Diabetes Complications; 1997; 11(2):123-30. PubMed ID: 9101398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy.
    Matzkies FK; Reinecke H; Regetmeier A; Breithardt G; Kerber S; Hohage H; Schaefer RM
    Nephron; 2001 Sep; 89(1):10-4. PubMed ID: 11528225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflection point of ascending aortic waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Ueda H; Nakayama Y; Tsumura K; Yoshimaru K; Hayashi T; Yoshikawa J
    Am J Hypertens; 2002 Sep; 15(9):823-6. PubMed ID: 12219879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty.
    Manegold C; Alwazzeh M; Jablonowski H; Adams O; Medve M; Seidlitz B; Heidland U; Häussinger D; Strauer BE; Heintzen MP
    Circulation; 1999 Mar; 99(10):1290-4. PubMed ID: 10077511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.
    Rossetti F; De Portu S; Menditto E; Scalone L; Bustacchini S; Cricelli C; Mantovani LG
    Pharmacol Res; 2006 Mar; 53(3):197-201. PubMed ID: 16406672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Technology in interventional cardiology: percutaneous transluminal coronary angioplasty.
    Stewart JT
    J Med Eng Technol; 1991; 15(3):99-106. PubMed ID: 1941986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fighting restenosis after coronary angioplasty: contemporary and future treatment options.
    Horlitz M; Sigwart U; Niebauer J
    Int J Cardiol; 2002 Jun; 83(3):199-205. PubMed ID: 12036521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients.
    Moreno PR; Fallon JT; Murcia AM; Leon MN; Simosa H; Fuster V; Palacios IF
    J Am Coll Cardiol; 1999 Oct; 34(4):1045-9. PubMed ID: 10520788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Imitative restenosis after percutaneous transluminal coronary angioplasty prevented by buyang huanwu decoction in rabbits].
    Hou C; He Q; Li S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 May; 21(5):359-63. PubMed ID: 12577422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.